Cyclo Therapeutics- Warrants (14/11/2025) Long Term Debt

As of the most recent data (September 2024), CYTHW shows a long-term debt of $7.1K. That compares with $27K in the prior-year period — down 73.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CYTHW's long-term debt is now $7.1K (was $27K) — a 73.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cyclo Therapeutics- Warrants (14/11/2025) is outperforming or lagging.

Tracking CYTHW's long-term debt over time shows whether Cyclo Therapeutics- Warrants (14/11/2025) is scaling, shrinking, or reshaping that part of the business. The current reading is $7.1K That compares with $27K in the prior-year period — down 73.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Cyclo Therapeutics- Warrants (14/11/2025)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $7.1K) with ownership activity and broader fundamentals.

Cyclo Therapeutics- Warrants (14/11/2025)'s long-term debt is $7.1K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.